Rabies vaccine: Developments employing molecular biology methods

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 11, Issue 2, 1999, Pages 137-147

  Paolazzi, Claudio Carlos ^a   Pérez, Oscar ^a   De Filippo, Javier ^a  

^a Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

Author keywords

DNA recombinant technology; Rabies vaccines

Indexed keywords

PLASMID VECTOR; RABIES VACCINE; RECOMBINANT VACCINE; SYNTHETIC PEPTIDE; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; BACULOVIRUS; DNA RECOMBINATION; GENETIC ENGINEERING; IMMUNOGENICITY; PLANT VIRUS; RABIES; RABIES VIRUS; VACCINIA VIRUS;

ADENOVIRIDAE; POXVIRIDAE; RABIES VIRUS; UNIDENTIFIED BACULOVIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0032815150     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02915807     Document Type: Article

References (47)

1. Pérez, O. and Paolazzi C. C. (1997) Production methods for rabies vaccine. J. Ind. Microbiol. Biotechnol. 18, 340-347.
2. Cox, J. H., Dietzehold, B., and Schneider, L. G. (1977) Rabies viruses glycoprotein II biological and serological characterization. Infect. Immunit. 16, 754-759.
3. Anilionis, A., Wunner W. H., and Curtis, P. J. (1981) Structure of the glycoprotein gene in rabies virus. Nature 294, 275-278.
4. Wiktor, T. J., Gyorgy, E., Schulmberger, H. D., Sokol, F., and Koprowski, H. (1973) Antigenic properties of rabies virus components. J. Immunol. 110, 269-276.
5. Sikes, R. K., Cleary, W. F., Koprowski, H., Wiktor, T. J., and Kaplan, M. M. (1977) Effective protection of monkeys against death from street virus by post-exposure administration of tissue culture rabies vaccine. Bull. W. H. O. 45, 1-11.
6. Flamand, A., Wiktor, T. J., and Koprowski, H. (1980) Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies related virus proteins II glycoprotein. J. Gen. Virol. 48a, 105-109.
7. Tsiang, H. and Lagrange, P. H. (1980) In vitro detection of cell mediated immunity in street rabies infection in mice. J. Gen. Virol. 47, 183-191.
8. Flamand, A., Wiktor, T. J., and Koprowski, H. (1980) Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies related virus proteins and the nucleocapside protein. J. Gen. Virol. 48, 97-104.
9. Dietzschold, B., Wunner, W. H., Wiktor, T. J., Lopes, A. D., Lafon, M., Smith, C. L., and Koprowski, H. (1983) Characterization of antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc. Natl. Acad. Sci. USA 80, 70-74.
10. Dietzschold, B., Wang, H., Rupprecht, C. E., Celis, M., Tollis, H., Herber Katz, E., and Koprowski, H. (1987) Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proc. Natl. Acad. Sci. USA. 84, 9165-9169.
11. Malek, L. T., Soostmeyer, G., Garvin, T., and James, E. (1984) The rabies glucoprotein gene is expressed in Escherichia coli as denatured polypeptide. Modern Approaches in Vaccines: Molecular and Chemical Basis of Virus Virulence and Immunity, Channock, R. M. and Lerner, R. A. (Eds.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1, 203-208.
12. Old, R. W. and Primrose, S. B. (1990) Principles of Genetic Manipulation. Blackwell Scientific Publications 4th on line ed., Oxford University Press, Oxford, UK.
13. Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
14. Sanger, F., Niklen, S., and Coulson, A. R. (1977) DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74, 5463-5467.
15. Yelverton, E., Norton, S., Obijeski, J. F., and Goedel, D. (1983) Rabies virus glycoprotein analogs biosynthesis in E. coli. Science 29, 614-620.
16. Mackett, M., Smith, G. L., and Moss, B. (1982) Vaccinia virus: A selectable eukaryotic cloning and expression vector. Proc. Natl. Acad. Sci. USA 79, 7415-7419.
17. Prevec, L., Campbell, J. B., Christie, B. S., Belbeck, L., and Graham, F. L. (1990) A recombinant adenovirus vaccine against rabies. J. Infect. Diseases 161, 27-30.
18. Schneider, M., Graham, F. L., and Prevec, L. (1989) Expression of the glycoprotein of vesicular stomatitis virus by infectious adenovirus vectors. J. Gen. Virol. 70, 417-427.
19. Graham, F. L. (1990) Adenovirus as expression vectors and recombinant vaccines. Trends Biotechnol. 8, 85-87.
20. Panicali, D. and Paoletti, E. (1982) Construction of poxvirus as cloning vectors insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc. Natl. Acad. Sci. USA 79, 4927-4931.
21. Kozak, M. (1981) Possible role of flanking nucleotides in the recognition of the AUG initiation codon by eukaryotic ribosomes. Nucleic Acid Res. 9, 5232-5233.
22. Kozack, M. (1984) Point mutations close to the AUG initiation codon affect the efficiency of translation of the rat preproinsulin in vivo. Nature 308, 241-246.
23. Kieny, M. P., Lathe, R., Dritten, R., Spehner, D., Skory, S., Schmitt, D., Wiktor, T. J., Koprowski, H., and Lecocq, J. P. (1984) Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature 312, 163-166.
24. Wiktor, T. J., Mac Farlan, R. J., Reagan, K. J., Dietzschold, B., Curtis, P. J., Wunner, W. H., Kieny, M. P., Lathe, R. M., Leçocq, J. P., Mackett, M., Moss, B., and Koprowski, H. (1984) Protection from rabies by vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc. Natl. Acad. Sci. USA 81, 7194-7198.
25. Piccini, A., Perkus, M. E., and Paoletti, E. (1987) Vaccinia virus as an expression vector. Methods Enzymol. 153, 545-563.
26. Blancou, J., Kieny, M. P., Lathe, R., Lecocq, J. P., Pastoret, P. P., Soulebot J. P., and Desmettre, P. (1986) Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature 322, 373.
27. Rupprecht, Ch. E., Wiktor, T. J., Johnston, D. H., Hamir, A. N., Dietzschold, B., Wunner, W. H., Glickman, L. T., and Koprowski, H. (1986) Oral immunization and protection of raccoons Procyon lotor with vaccinia rabies glycoprotein recombinant virus vaccine. Proc. Natl. Acad. Sci. USA 83, 7947-7950.
28. Brochier, B., Kieny, M. P., Costy, F., Coppens, P., Bauduin, B., Lecocq, J. P., Languet, B., Chappuis, G., Desmettre, P., Afiademanyo, K., Libois, R., and Pastoret, P. P. (1991) Large scale eradication of rabies using recombinant vaccinia rabies vaccine. Nature 354, 520-522.
29. Summer, J. W., Fekadu, M., Shaddock, J. H., Esposito J. J., and Bellini, W. J. (1991) Construction of vaccinia virus recombinants that express the rabies nucleoprotein and protective immunization of mice. J. Virol. 183, 703-710.
30. Fekadu, M., Summer, J. W., Shaddock, J. H., Sanderlin, D. W., and Baer, G. M. (1992) Sickness and recovery of dogs challenged with street rabies virus after vaccination with vaccinia virus recombinant expressing rabies virus N protein. J. Virol. 66, 2601-2604.
31. Prevec, L., Schneider, M., Rosenthal, K. I., Belbeck, L. W., Derbyshire, J. B., and Graham, F. L. (1989) Use of adenovirus based vectors for antigen expression in animals. J. Gen. Virol. 70, 429-434.
32. Xiang, Z. Q., Yiping, Y., Wilson, J. M., and Erlt, H. C. J. (1996) A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219, 220-227.
33. Wang, Y., Xiang, Z. Q., Pasquini, S., and Erlt, H. C. J. (1997) The use an El-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus. J. Virol. 71, 3677-3683.
34. Fries, L. F., Tartaglia, J., Taylor, J., Kauffman, E. K., Meignier, B., Paoletti, E., and Plotkin, S. (1996) Human safety and immunogenicity of canaripox-rabies glycoprotein recombinant vaccine an alternative poxvirus vector system. Vaccine 14, 428-434.
35. Prehaud, C., Takehara, K., Flamand, A., and Bishop, D. H. L. (1989) Immunogenic and protective properties of virus glycoprotein expressed by baculovirus vectors. Virology 173, 390-399.
36. Prehaud, C., Harris, R. D., Fulop, V., Koh, Ch. L., Wong, J., Flamand, A., and Bishop, D. H. L. (1990) Expression, characterization and purification of phosphorylated rabies nucleoprotein synthesized in insect cells by baculovirus. Virology 178, 486-497.
37. Matsura, Y., Possee, R., Overton, H. A., and Bishop, D. H. L. (1987) Baculovirus expression vectors, the requirements of expression proteins including glycoproteins. J. Gen. Virol. 68, 1233-1250.
38. Fu, Z. F., Dietzschold, B., Schumacher, C. L., Wunner, W. H., Ertl, H. C. J., and Koprowski, H. (1991) Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as vaccine. Proc. Natl. Acad. Sci. USA 88, 2001-2005.
39. Yusibov, V., Modelska, A., Steplewski, K., Agadjanyan, M., Weiner, D., Hooper, D. C., and Koprowski, H. (1997) Antigens produced in plants by infections with chimeric plant-viruses immunize against rabies virus and HIV-1. Immunology 94, 5784-5788.
40. Xiang, Z. Q., Spitalnik, S., Tran, M., Wunner, W. H., Cheng, J., and Erlt, H. C. J. (1994) Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199, 132-140.
41. Xiang, Z. Q. and Erlt, H. C. J. (1995) Manipulation of the immune response to a plasmid encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2, 129-135.
42. Crick, J. and Brown F. (1969) Viral subunits for rabies vaccination. Nature 222, 92.
43. Wunner, V. H., Dietzschold, B., Curtis, P. J., and Wiktor, T. J. (1983) Rabies subunit vaccines. J. Gen. Virol. 64, 1649-1656.
44. Morein, B. and Simons K. (1985) Subunit vaccines against enveloped viruses: Virosomes, micelles and other protein immune complex. Vaccine 3, 83-93.
45. Koprowski, H. (1988) Glimpses into the future of rabies research. Rev. Infect. Dis. 10 (suppl. 4), 810-813.
46. Castingolles, N., Morgeaux, S., Gontier-Jallet, C., Samain, D., Betbeder, D., and Perrin, P. (1996) A new family of carriers (biovectors) enhances the immunogenicity of rabies antigens. Vaccine 14, 1353-1360.
47. Ertl, H., Varga, Y., Xiang, Z. Q., Kaiser, K., La Donna, E., and Otvos, L. (1996) Poly (DL. lactideco-gycolide) microspheres as carriers for peptide vaccine. Vaccine 14, 879-885.